机构：[1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China[2]Capital Med Univ, Bejing Tongren Hosp, Dept Hematol, Beijing, Peoples R China首都医科大学附属同仁医院[3]Tianjin Med Univ, Dept Radio Therapy, Canc Inst & Hosp, Tianjin, Peoples R China[4]Ningbo Univ, Dept Radio Chemotherapy, Affiliated Peoples Hosp, Ningbo, Peoples R China[5]Chinese Acad Med Sci & Peking Union Med Coll, Dept Pathol, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China[6]Chinese Acad Med Sci & Peking Union Med Coll, Dept Nucl Med, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
第一作者机构：[1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Wang X-Y.,Gao L-R.,Wang L.,et al.Initial results of the multicenter phase II trial of a novel hypofractionated low-dose radiotherapy for indolent non-Hodgkin lymphoma[J].ANNALS OF ONCOLOGY.2024,35:S601-S601.doi:10.1016/j.annonc.2024.08.863.
APA：
Wang, X-Y.,Gao, L-R.,Wang, L.,Zhang, X.,Chen, K....&Qi, S..(2024).Initial results of the multicenter phase II trial of a novel hypofractionated low-dose radiotherapy for indolent non-Hodgkin lymphoma.ANNALS OF ONCOLOGY,35,
MLA：
Wang, X-Y.,et al."Initial results of the multicenter phase II trial of a novel hypofractionated low-dose radiotherapy for indolent non-Hodgkin lymphoma".ANNALS OF ONCOLOGY 35.(2024):S601-S601
医学